2015 Meeting
- NIR Calibration Life Cycle
- Strategic goals for Rapid Micro Methods: Moving beyond technologies to solutions
- Key initiatives controlling raw material variability
- NIST Acedemic Consortium
- Applications of PAT to continuous DP Manufacturing
- PAT in ADC production
- Genentech Pilot Plant Tours
- Disposable sensors
2014 Meeting
-
Model validation, maintenance, Method Transfer and standards preparation, Parallel Testing subtopic
-
Live meeting with Christine Moore, FDA
-
Big Data on lifecycle management
-
Rapid micro and biological methods
-
Disposable sensor guidelines
-
Standardization of electronic data exchange formats between suppliers and Pharma
-
PAT Considerations for Continuous DP Manufacturing
-
Backward compatibility of software for PAT and Modeling and regulatory implications
The 2013 PPAR was hosted by BMS on October 2nd and 3rd in New Brunswick New Jersy
- Raw Materials Variability/Global Supply Chain
- Rapid Micro Methods
- Disposable Sensors and Disposable Processing Equipment
- Drug product development and manufacturing operations
- Biopharmaceutical real-time analytical suite
- Regulatory expectations for RTRt and in-process methods
- Business strategies for applying real-time analytics
- PAT and contract manufacturing
- PAT data management software
- Continuous manufacturing
- New technologies
- API - chemical development laboratory
- Clinical supplies manufacturing
-
The 2012 PPAR was hosted by Eli Lilly in Indianapolis, IN
- Raw Materials Variability/RM CQAs/Global Supply Chain
- Business Case for PAT
- Approaches to Collaborative Instrument Development
- Issues Associated with CRO/CMO in a QbD World
- Specs and Statistics for High N
- Recent Regulatory Experiences and Industry Standards Sharing
- Discussion of New/Emerging Technologies, Including Disposable Sensing
- Discussions with Regulatory Authorities
-
The 2011 PPAR was hosted by Amgen on September 26-27 in West Greenwich Rhode Island
- Raw Materials Variability/RM CQAs/Global Supply Chain
- QbD-PAT: PAT Tools enabling Control Strategy for CQAs, Regulatory Updates
- Data Management for PAT, IT infrastructure, MVDA (online/offline, product lifecycle)
- Continuous Processing and Role of PAT
- PAT Hot Topics: Technology gaps, New technologies/applications: Small and Large molecules
- PAT Benefits Case
- PAT at Contract Manufacturing Organizations
- Technology Development Strategies
- Tour of Process Development Labs and PAT Demos
- Sample Size Determination (Sept. 12-13, 2011, PQRI meeting update)
-
The 2010 PPAR was hosted by Vertex on October 26-27 in Cambridge, MA
- Road map for using PAT as a technology/enabler for Process Understanding
- PAT IT infrastructure
- New Technologies
- Aimed at small molecules
- Aimed at large molecules
- Outstanding application opportunities/technology gaps
- Raw material characterization (verification and conformity)
- Recent regulatory activities/discussions/interactions
- What is happening in the ‘Rest of the World’; sharing learnings/information on guidances/filing experiences etc
- Regulatory submissions including RTR
- Continuous Processing
-
|
The 2009 PPAR was hosted by Novartis on October 13-14 in East Hanover, NJ and Suffern, NY
The 2008 PPAR was hosted by Biogen Idec, on October 7-8 in the Research Triangle Park (RTP), NC.
The 2007 PPAR was hosted by Merck & Co., Inc., on October 9-11 in West Point, PA. Thirty-five PAT experts representing 20 pharmaceutical companies participated in two days of discussions.
For the agenda from the 2007 PPAR, click here. A selection of topics covered at the meeting include:
- What is the (current) definition of PAT? What is its role in/relationship to QbD?
- PAT/QbD: Review of selected current actively-pursued standards, white papers, and guidances (including ASTM E 55, ISPE white paper, PhRMA teams, etc.)
- Experiences from a PAT implementation example in the pharmaceutical environment
- Experiences from a PAT implementation example in the bio-pharm environment
- Experiences with PAT studies using multivariate process analysis and use of latent variables
- PAT implementation with contract manufacturers
Back to top
PPAR 2006 was hosted by Amgen from October 17-19 at the University Tower Hotel in Seattle,
Washington,
USA. For the agenda of PPAR 2006, click here for the Word or PDF file.
|
PPAR 2006 delegates during the tour of the Amgen Helix facility. |
2006 Benchmarking Survey
The 2006 Benchmarking Survey is being compiled and will be posted here.
2006 Discussions
There are no formal presentations at PPAR, but instead a series of discussion topics.
Here is a selection of slides used to kick off the conversations in 2006.
Back to top
PPAR 2005 was held from September 27-29 on the Pfizer La Jolla campus in San Diego, California, U.S.A.
Download Full Size Picture
For reference, here is a detailed schedule of activities at the 2005 meeting. Due to the interactive, informal nature of the roundtable discussion format, the schedule was subject to some on-the-fly modification.
2005 Benchmarking Survey
The 2005 Benchmarking Survey is being compiled and will be posted here.
2005 Discussions Here is a sample of slides used to kick off the conversations in 2005:
Back to top
PPAR 2004 was held at the Genentech facility in South San Francisco, California, U.S.A.
2004 Benchmarking Survey
A fundamental purpose of PPAR is the ability to share best practices and do benchmarking. Here are the results from 2004.
(Disclaimer: This is not a statistically rigorous study and should be viewed as a 'for information only' resource. Survey results are used for seeding discussion on current practices and trends.)
2004 Discussions
Here is a sample of slides used to kick off the conversations (and debates) in 2004:
Back to top
PPAR 2003 was held on the University of Michigan campus in Ann Arbor, Michigan, U.S.A.
Download Full Size Picture
2003 Discussions
Back to top
|
|
| | | |
|